Emergent BioSolutions (EBS) Income towards Parent Company: 2010-2025
Historic Income towards Parent Company for Emergent BioSolutions (EBS) over the last 16 years, with Sep 2025 value amounting to $51.2 million.
- Emergent BioSolutions' Income towards Parent Company fell 55.40% to $51.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.9 million, marking a year-over-year increase of 136.35%. This contributed to the annual value of -$190.6 million for FY2024, which is 74.94% up from last year.
- According to the latest figures from Q3 2025, Emergent BioSolutions' Income towards Parent Company is $51.2 million, which was up 526.67% from -$12.0 million recorded in Q2 2025.
- In the past 5 years, Emergent BioSolutions' Income towards Parent Company ranged from a high of $177.9 million in Q4 2021 and a low of -$283.1 million during Q2 2024.
- Over the past 3 years, Emergent BioSolutions' median Income towards Parent Company value was -$31.3 million (recorded in 2024), while the average stood at -$76.7 million.
- In the last 5 years, Emergent BioSolutions' Income towards Parent Company skyrocketed by 657.60% in 2021 and then crashed by 4,932.43% in 2023.
- Emergent BioSolutions' Income towards Parent Company (Quarterly) stood at $177.9 million in 2021, then plummeted by 137.66% to -$67.0 million in 2022, then grew by 26.12% to -$49.5 million in 2023, then spiked by 36.77% to -$31.3 million in 2024, then crashed by 55.40% to $51.2 million in 2025.
- Its Income towards Parent Company was $51.2 million in Q3 2025, compared to -$12.0 million in Q2 2025 and $68.0 million in Q1 2025.